eFFECTOR Therapeutics, Inc. (EFTR) Social Stream
eFFECTOR Therapeutics Inc (EFTR) Price Targets From Analysts
Use the tables below to see what analysts covering eFFECTOR Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
EFTR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EFTR as an investment opportunity.
- In terms of how eFFECTOR Therapeutics Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 292.32% of that group.
- EFTR has a lower variance in analysts' estimates than -188.8% of all US stocks.
- In terms of how eFFECTOR Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 68.94% of that group.
- In terms of how eFFECTOR Therapeutics Inc fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 193.78% of that group.
Is EFTR a Buy, Hold or Sell? See the POWR Ratings now!